Editorial Policy > Editorial Policy

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

본문

Editorial Policy

The Oriental Pharmacy and Experimental Medicineaims at bridging the gap between Oriental pharmacy and modern experimental medicine. It publishes original articles related to the observation and experimental investigation of the biological activities and clinical applications of natural substances of all cultures. It is published quarterly and is the official publication of the International Society for Korean Medicine. Submitted manuscripts must be in English.

The editorial policies are the responsibility of the Editor-in-Chief and the Editorial Board under the general authority of the Publications Committee and the Council.

After editorial review, the JOURNAL publishes papers based on the original research that are judged to make a substantial contribution to the understanding of any area of natural substances of all cultures. Manuscripts may be submitted for consideration as Research Articles or Communications. The JOURNAL also publishes Minireviews. Communications are intended to present new information of exceptional interest and novelty to readers of the JOURNAL.

As a condition of publication, all authors must transfer copyright to the International Society for Korean Medicine. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

All manuscripts submitted to the JOURNAL are critically reviewed. It is the responsibility of the Editor-in-Chief and the Editorial Board to determine their suitability for the publication. After receipt of a manuscript by the Editor, it is sent to a member of the Editorial Board. The Board member then makes a definitive recommendation for acceptance without change, acceptance after minor revision, reevaluate after major revision, or rejection based on the scientific merit and technical quality of the studies reported. Referees may be consulted when additional expertise is required; however, decisions on manuscripts are often made on the basis of a single review.

All Board members and referees who review a manuscript remain unknown to the authors. Every manuscript is treated by the Editors and referees as privileged information, and they are instructed to exclude themselves from review of any manuscript that might involve a conflict of interest or the appearance thereof. The main criteria for the acceptability of a manuscript are its originality and scientific importance. Manuscripts judged lacking in these respects will be declined, even if the experimental work appears technically sound. This policy permits rejection of a manuscript solely on the judgment of the Editorial Board that the studies reported are insufficiently original or important to merit publication in the JOURNAL. If the reviewer does not recommend a manuscript for publication, the Associate Editor can reject it without further review. In some instances, the Editor-in-Chief may seek a second opinion from another reviewer but is not obliged to do so.

 


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View